Woodzicka v. Artifex Ltd.

25 F. Supp. 2d 930, 42 Fed. R. Serv. 3d 1109, 1998 U.S. Dist. LEXIS 17749, 1998 WL 774646
CourtDistrict Court, E.D. Wisconsin
DecidedNovember 6, 1998
Docket94-C-1379
StatusPublished
Cited by3 cases

This text of 25 F. Supp. 2d 930 (Woodzicka v. Artifex Ltd.) is published on Counsel Stack Legal Research, covering District Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Woodzicka v. Artifex Ltd., 25 F. Supp. 2d 930, 42 Fed. R. Serv. 3d 1109, 1998 U.S. Dist. LEXIS 17749, 1998 WL 774646 (E.D. Wis. 1998).

Opinion

DECISION AND ORDER RE: PLAINTIFFS’ RULE 41(a)(2) MOTION FOR VOLUNTARY DISMISSAL

CALLAHAN, United States Magistrate Judge.

Background

This action was commenced on December 19, 1994, when the plaintiffs, David Woodzic-ka (“Woodzicka”) and Jason Nelson (“Nelson”), filed a complaint in this district asserting a host of claims against the defendant, Artifex Limited (“Artifex”). The plaintiffs’ claims stem from each of them having allegedly incurred damages from the spinal fixa *932 tion systems utilizing pedicle screws, which were implanted posteriorly into the vertebrae of their spines. Their complaint against Ar-tifex was transferred to the United States District Court for the Eastern District of Pennsylvania to be made a part of the multi-district litigation proceedings captioned In Re: Orthopaedic Bone Screw Products Liability Litigation, MDL 1014, the Honorable Louis Bechtle presiding. Eventually, on July 30, 1997, this action was remanded to this district after the Judicial Panel on Multi-district Litigation had determined that coordinated or consolidated pretrial proceedings in it had been completed and that, therefore, remand as provided in 28 U.S.C. § 1407(a) was appropriate. After having been originally assigned to several other judges in this district, this action eventually found its way to this court’s docket on February 13,1998. On April 3,1998, and then again on May 1, 1998, scheduling conferences were conducted. On May 1,1998, dates for the exchange of expert reports and for the cut-off of all case specific discovery were set. A trial date of December 7,1998, was also set.

Thereafter, several discovery skirmishes arose and were addressed by the court. Additionally, the defendant filed, inter alia, several motions for summary judgment. Specifically, on June 29,1998, Artifex filed a motion-for partial summary judgment “with respect to all issues relating to the alleged failure by Artifex to obtain pre-market approval of its products from the Food and Drug Administration (‘FDA’) and its alleged failure to comply with the FDA’s reporting requirements on the ground that the products upon which plaintiffs [based] their causes of action were custom made, and therefore expressly exempted from the FDA pre-market approval and reporting requirements ... [and that therefore] lack of FDA approval or compliance with FDA reporting requirements [could not] provide a basis for imposition of liability on Artifex.” (Defendant’s June 29, 1998, Motion for Partial Summary Judgment). The plaintiffs filed submissions in opposition to this motion and, with the filing of Artifex’s reply submissions on August 12, 1998, this particular motion was fully briefed and ready for resolution.

Thereafter, on September 8, 1998, Artifex filed another motion for summary judgment. In that motion “Artifex seeks summary judgment on Plaintiffs’ claims for strict liability (Count I), negligence (Count II), implied and express warranty (Count III), fraud (Count IV), violation of Wisconsin statute § 100.18 (Count V), intentional concealment (Count VI), and negligent infliction of emotional distress (Count VII).” (Defendant’s September 8,1998, Motion for Summary Judgment). As stated by Artifex in its September 8, 1998, brief:

Throughout the Complaint are allegations that Artifex failed to obtain FDA approval for its devices, misrepresented the FDA’s status of its devices and concealed information from the FDA. These allegations are the subject of a pending Motion Partial Summary Judgment filed by Artifex ... The basis for that Motion is Artifex’s contention that the devices implanted into Messrs. Woodzieka and Nelson’s spines were each custom made. As such, those devices are expressly exempt from any FDA premarket approval and reporting requirements pursuant to § 360j(b) of the Medical Device Amendment of 1976 (“MDA”), 21 U.S.C. § 360c, et seq. Therefore, lack of FDA approval cannot form the basis for the imposition of liability on Arti-fex. Further, Artifex is entitled to summary judgment on all claims involving alleged misrepresentations to the FDA and/or alleged violations of the MDA, because the MDA does not provide a private right of action. Finally, the Custom Made Motion noted that plaintiffs’ elaims failed to meet the standard for legal causation. Artifex now moves for summary judgment on the plaintiffs’ remaining claims on the basis that such claims are barred by the applicable statute of limitations. In addition, certain claims are barred by reason of the dismissal of such causes of action in the Multidistrict Litigation proceeding known as In Re Orthopaedic Bone Screw Product Liability Litigation, MDL Docket No. 1014. Finally, certain of plaintiffs’ causes of action have necessary elements that cannot proven by plaintiffs.

Id. at pp. 2-3.

Thus, with the filing of this particular motion for summary judgment, all of the plain *933 tiffs’ claims became targets of motions for summary judgment.

The plaintiffs’ materials in response to Ar-tifex’s September 8, 1998, motion for summary judgment were due to be filed 30 days thereafter, i.e., on October 8, 1998. No such materials were filed. Instead, on October 8, 1998, the plaintiffs filed a motion for voluntary dismissal, without prejudice and without costs, pursuant to Rule 41(a)(2), Fed.R.Civ.P. The grounds given for such motion are as follows:

Given developments in a recent trial in this District involving the same Defendant, Case No. 0533, Plaintiffs make this Motion, having reached the conclusion following that trial, that plaintiffs are not likely to be successful in this case.

(Plaintiffs’ Rule 41 Motion for Voluntary Dismissal).

In timely fashion, Artifex filed a “Memorandum in Partial Opposition to Plaintiffs’ Motion for Voluntary Dismissal,” arguing that the plaintiffs’ motion for voluntary dismissal should be denied to the extent that it requests dismissal without either prejudice or costs. Instead, Artifex argues that this court should dismiss the action with prejudice, and should assess costs. On October 30, 1998, the plaintiffs filed their reply in support of their motion for voluntary dismissal. Thus, the plaintiffs’ motion for voluntary dismissal is fully briefed and ready for resolution.

Venue is proper under 28 U.S.C. § 1391. The parties have consented to magistrate judge jurisdiction pursuant to 28 U.S.C. § 636(c) and Local Rule 13.05(a). Jurisdiction is based on 28 U.S.C. § 1332, diversity of citizenship and an amount in controversy exceeding ISOjOOO.OO. 1 For the reasons which follow, the plaintiffs’ motion for voluntary dismissal will be granted in part and denied in part, if, as explained below, the plaintiffs do not withdraw said motion on or before November 20,1998, at 5:00 p.m.

Analysis

Rule 41(a)(2), Fed.R.Civ.P., provides, in pertinent part:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Shady Records, Inc. v. Source Enterprises, Inc.
371 F. Supp. 2d 394 (S.D. New York, 2005)
Ruth v. Purdue Pharma Co.
225 F.R.D. 434 (S.D. New York, 2004)
Gonzales v. City of Topeka Kansas
206 F.R.D. 280 (D. Kansas, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
25 F. Supp. 2d 930, 42 Fed. R. Serv. 3d 1109, 1998 U.S. Dist. LEXIS 17749, 1998 WL 774646, Counsel Stack Legal Research, https://law.counselstack.com/opinion/woodzicka-v-artifex-ltd-wied-1998.